Dan Frissell
Family Medicine · Ste Genevieve, MONPI 1407829849
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2022 at $721 and has fallen 62.6% since, to $270 in 2024.
Across 149 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$746
- Johnson & Johnson$343
- Lilly USA, LLC$271
- Amgen$226
- Pfizer$158
- Novo Nordisk$89
- plus $918 from 22 others
What the payments were for
- Food & beverage$2,751100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $746 |
| Johnson & Johnson | 19 | $343 |
| Lilly USA, LLC | 15 | $271 |
| Amgen | 11 | $226 |
| Pfizer | 9 | $158 |
| Novo Nordisk | 6 | $89 |
| Mallinckrodt Hospital Products Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| AstraZeneca(2 entities) | 5 | $77 |
| Novartis | 4 | $74 |
| Grifols USA, LLC | 4 | $63 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Radius Health, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| GSK | 3 | $47 |
| Mallinckrodt Enterprises LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $34 |
| Sunovion Pharmaceuticals Inc. | 3 | $31 |
| Amarin Pharma, Inc. | 2 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Organon | 1 | $22 |
| Abbott | 1 | $21 |
| Apria Healthcare LLC | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Merck | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,751 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 37 | $114,648 |
| EliquisApixaban | 54 | $17,663 |
| FarxigaDapagliflozin Propanediol | 30 | $11,299 |
| JardianceEmpagliflozin | 28 | $10,126 |
| XareltoRivaroxaban | 31 | $10,107 |
| EntrestoSacubitril/Valsartan | 30 | $9,761 |
| LinzessLinaclotide | 13 | $7,409 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,880 |
| MyrbetriqMirabegron | 12 | $2,769 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 18 | $2,437 |
| Novolog FlexpenInsulin Aspart | 13 | $1,853 |
| Divalproex Sodium | 25 | $1,835 |
| Quetiapine Fumarate | 57 | $1,711 |
| Duloxetine Hcl | 46 | $1,665 |
| Atorvastatin Calcium | 123 | $1,514 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $158 | $17,66354 claims |
| AstraZenecaFarxiga | $77 | $11,29930 claims |
| Johnson & JohnsonXarelto | $343 | $10,10731 claims |
| NovartisEntresto | $74 | $9,76130 claims |
| AbbVieLinzess | $746 | $7,40913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Ste Genevieve
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.